Christian Copley
Optometrist · Lakeland, FLNPI 1265665699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 30.3% of the total. Reporting peaked in 2021 at $713 and has fallen 61.1% since, to $278 in 2025.
Across 86 payments — averaging $36.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$954
- Coopervision Inc.$417
- Bausch & Lomb Americas Inc.$338
- Sight Sciences, Inc.$273
- Alcon$168
- Regeneron$132
- plus $871 from 13 others
What the payments were for
- Food & beverage$3,08698%
- Education$181%
- Gifts$191%
- Entertainment$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 43 | $954 |
| Coopervision Inc. | 9 | $417 |
| Bausch & Lomb Americas Inc. | 5 | $338 |
| Sight Sciences, Inc. | 4 | $273 |
| Alcon | 7 | $168 |
| Regeneron | 1 | $132 |
| Sun Pharmaceutical Industries Inc. | 1 | $125 |
| Amgen | 1 | $122 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $107 |
| Shire North American Group Inc | 1 | $100 |
| Tarsus Pharmaceuticals, Inc. | 1 | $96 |
| Optos, Inc. | 3 | $75 |
| AbbVie | 2 | $72 |
| Optovue, Inc. | 1 | $64 |
| Novartis | 2 | $36 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,153 in reported general payments places this provider in the 80th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 103 | $831 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 36 | $419 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 12 | $397 |
| Timolol Maleate | 31 | $249 |
| Ofloxacin | 16 | $189 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Lakeland
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
- Robert DavisPembroke Pines$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.